Using Subcutaneous Insulins to Manage Mild to Moderate Diabetic Ketoacidosis: A Simpler Protocol that May Save Millions in the Developing World

Diabetic ketoacidosis (DKA), known to be a complex metabolic state of hyperglycemia, ketosis, and acidosis leading to osmotic diuresis, dehydration and tissue hypoxia, is the most common hyperglycemic emergency in patients with diabetes mellitus. It carries, if not properly managed, a high mortality rate. Further, most deaths attributed to DKA might have been prevented if a proper management protocol has been followed [1-3].